07:00 , Jul 28, 2016 |  BC Innovations  |  Finance

MRCT looks east

MRC Technology (MRCT) is broadening its reach to Asia with a new strategy that extends beyond the source and geography of its original mission to serve as the tech transfer arm of the U.K.'s Medical...
07:00 , Mar 9, 2015 |  BC Week In Review  |  Company News

Qiagen deal

Qiagen’s Qiagen Marseille subsidiary proposed to spin out its leukemia diagnostic manufacturing capacity and other R&D into a standalone company named HalioDx . HalioDx will be granted a non-exclusive license to Qiagen’s pyrosequencing technology. The...
07:00 , May 5, 2014 |  BC Week In Review  |  Financial News

Biotage financial update

Biotage said its board authorized the repurchase of up to 10% of the company's outstanding shares. Biotage, which closed Friday at SEK12 has 64.7 million shares outstanding. Biotage AB (SSE:BIOT), Uppsala, Sweden   Business: Supply/Service...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Clinical News

cobas KRAS Mutation Test regulatory update

The U.K.'s NICE issued draft guidance recommending 2 PCR-based tests to determine K-Ras (KRAS) mutation status in adults with metastatic colorectal cancer (mCRC). The committee backed use of therascreen KRAS RGQ PCR Kit from Qiagen...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Swedish Orphan Biovitrum management update

Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden   Business: Hematology, Endocrine/Metabolic, Neurology   Hired: Mats-Olof Wallin as interim CFO, formerly CFO of Biotage AB ; he replaces Annika Muskantor  ...
07:00 , May 7, 2012 |  BC Week In Review  |  Company News

JS Genetics sales and marketing update

JS Genetics launched XCAT-KS in the U.S. to diagnose Klinefelter syndrome and other male sex chromosome aneuploidies. The PCR/pyrosequencing-based test will be processed at JS Genetics' CLIA-certified lab. JS Genetics Inc. , Short Hills, N.J....
07:00 , May 7, 2012 |  BC Week In Review  |  Financial News

Biotage financial update

Biotage said its board authorized the repurchase of up to 10% of the company's outstanding shares. Biotage, which closed Friday at SEK7.40, has 79.6 million shares outstanding. Biotage AB (SSE:BIOT), Uppsala, Sweden   Business: Supply/Service...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Company News

Qiagen, Shanghai Jiao Tong University other news

Qiagen partnered with the university's Bio-X Center to open a joint translational medicine lab in Shanghai. Qiagen will provide its pyrosequencing instrument Pyromark Q24MDx and QIAcube instruments and related products. Pyrosequencing is a method for...
07:00 , May 16, 2011 |  BC Week In Review  |  Financial News

Biotage financial update

Biotage said its board authorized the repurchase of up to 10% of the company's outstanding shares. Biotage, which closed Friday at SEK7.00, has 79.6 million shares outstanding. Biotage AB (SSE:BIOT), Uppsala, Sweden   Business: Supply/Service...
07:00 , Mar 21, 2011 |  BC Week In Review  |  Company News

Transgenomic, Dana-Farber Cancer Institute deal

The partners expanded a 2009 deal under which Transgenomic received exclusive, worldwide rights to commercialize the institute's COLD-PCR high-sensitivity mutation detection technology for Sanger sequencing and mitochondrial DNA analysis. The expanded deal now includes rights...